CIK 0000886163
- Large accelerated filer
LIGAND PHARMACEUTICALS INC
Sign in to watch- Tickers
- LGND LGNDZ LGNXZ LGNYZ LGNZZ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 770160744
- Phone
- +1 858-550-7500
- Business address
- 7111 FAIRWAY DRIVE, SUITE 302, PALM BEACH GARDENS, FL, 33418
- Former names
- LIGAND PHARMACEUTICALS
Securities
- LGND Common Stock Nasdaq
- LGNDZ Common stock OTC
- LGNXZ Common stock OTC
- LGNYZ Common stock OTC
- LGNZZ Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,384,247
- in 9 filings, $4.7M under 10b5-1 plans
Net −$7,384,247. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-04-24 | Davis Todd C Director | Grant or award | +925 | 35,278 | ||
| 2015-04-24 | Davis Todd C Director | Grant or award | +501 | 35,779 | ||
| 2015-04-24 | Davis Todd C Director | Grant or award · Non-Qualified Stock Option (right to buy) | +2,754 | $89.75 | $247K | 2,754 |
| 2015-04-24 | Aryeh Jason Director | Grant or award | +925 | 58,337 | ||
| 2015-04-24 | Aryeh Jason Director | Grant or award · Non-Qualified Stock Option (right to buy) | +2,754 | $89.75 | $247K | 2,754 |
| 2015-03-19 | Patel Sunil Director | Sale | −4,591 | $74.42 | $342K | 37,100 |
| 2015-03-16 | Berkman Charles S VP, Gen. Counsel & Secretary | Sale | −6,000 | $74.51 | $447K | 25,989 |
| 2015-03-16 | Berkman Charles S VP, Gen. Counsel & Secretary | Exercise or conversion | +1,134 | $14.47 | $16K | 27,123 |
| 2015-03-16 | Berkman Charles S VP, Gen. Counsel & Secretary | Sale | −1,134 | $74.58 | $85K | 25,989 |
| 2015-03-16 | Berkman Charles S VP, Gen. Counsel & Secretary | Exercise or conversion | +4,130 | $21.92 | $91K | 30,119 |
| 2015-03-16 | Berkman Charles S VP, Gen. Counsel & Secretary | Sale | −4,130 | $74.58 | $308K | 25,989 |
| 2015-03-16 | Berkman Charles S VP, Gen. Counsel & Secretary | Exercise or conversion · Employee Stock Option (right to buy) | −1,134 | 0 | ||
| 2015-03-16 | Berkman Charles S VP, Gen. Counsel & Secretary | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −4,130 | 4,764 | ||
| 2015-03-02 | Herman Melanie J Director of Accounting | Sale | −535 | $60.69 | $32K | 2,986 |
| 2015-02-19 | Herman Melanie J Director of Accounting | Sale | −510 | $57.84 | $29K | 3,521 |
| 2015-02-10 | Herman Melanie J Director of Accounting | Grant or award | +1,200 | 4,031 | ||
| 2015-02-10 | Herman Melanie J Director of Accounting | Grant or award · Employee Stock Option (right to buy) | +9,000 | $56.26 | $506K | 9,000 |
| 2015-02-10 | FOEHR MATTHEW W EVP and COO | Grant or award | +13,112 | 68,128 | ||
| 2015-02-10 | FOEHR MATTHEW W EVP and COO | Grant or award · Employee Stock Option (right to buy) | +42,113 | $56.26 | $2.4M | 42,113 |
| 2015-02-10 | Berkman Charles S VP, Gen. Counsel & Secretary | Grant or award | +4,556 | 31,989 |
Page 70 of 86 · 1,712 trades